High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study—VitCov Trial

BACKGROUND: The coronavirus disease 19 (COVID-19) pandemic has caused millions of deaths, and new treatments are urgently needed. Factors associated with a worse COVID-19 prognosis include old age (> 65 years), ethnicity, male sex, obesity, and people with comorbidities. Furthermore, vitamin D de...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaun, Fabienne, Boesing, Maria, Lüthi-Corridori, Giorgia, Abig, Kristin, Makhdoomi, Anja, Bloch, Nando, Lins, Christina, Raess, Andrea, Grillmayr, Victoria, Haas, Philippe, Schuetz, Philipp, Gabutti, Luca, Muser, Jürgen, Leuppi-Taegtmeyer, Anne B., Giezendanner, Stéphanie, Brändle, Michael, Leuppi, Jörg D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814790/
https://www.ncbi.nlm.nih.gov/pubmed/35120577
http://dx.doi.org/10.1186/s13063-022-06016-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814790/
https://www.ncbi.nlm.nih.gov/pubmed/35120577
http://dx.doi.org/10.1186/s13063-022-06016-2

Ejemplares similares